Kochi: Efforts by developed countries to monopolize the production of Coronavirus vaccines and hoard them, a phenomenon described as ‘nationalism vaccine’, can weaken the war against a pandemic and cause spawning of new virus variants with vaccine resistance, a leading medical expert be warned.
It assumes the significance after the massive spread of omicrons and the detection of new Covid-19 variants in France, while being named after ‘IHU’.
“Narrow behavior, self-centered, may not only turn into epidemiologists to defeat themselves and clinically counterproductive, but are also bound to extend the pandemic by capturing transmission in and in an unprotected population,” according to Prof (DR) YATISH Agarwal, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
If the majority of the world’s population becomes unclear, tolls taken by Covid-19 disease will continue to bring in catastrophe, Prof.
Agarwal wrote in an article that appeared in Manorama Yearbook-2022.
Making a strong tone for a fair vaccine distribution and rapid immunization of people around the world, he said the politicization of the vaccine distribution proved to be counterproductive for global democracy practices.
Dr.
Agarwal argues that the practice betrays ‘moral crass’ in the background who the declaration is ‘health for all’.
Nationalism vaccine, driven by a market approach, hopefully a snowball into a situation that can be wrong.
“In such a setting, the virus is bound to grow and multiply and spawn new virus mutations.
This new Avatar Coronavirus can cause vaccine resistance, and trigger a new threat to mankind,” Dr.
Agarwal wrote.
Given the small scale of vaccine production, expanding protection against the entire global population is not a meaningful task, according to him.
“The challenge deepens, given that most vaccines need at least two jabs to instill primary protection, and are very possible, one or more of the next booster shot to maintain immunity.” Dr.
Agarwal, who is also Dean, Medical University, Teacher University Gobind Singh Indraprastha, New Delhi, said the nations of rich in their economy and very superior scientific and pharmaceutical abilities have forced the non-equivalent run on the supply of the Coronavirus vaccine, and left Little or without provisions for third world citizens.
A small contingent of rich countries – Australia, Canada, Japan, England, USA, and the European Union – through investment in making vaccines and advance purchasing agreements, guaranteeing almost half of the 2021 planned supplies from leading vaccine candidates, Dr.
Agarwal said.
“Together, these countries contributed only 14 percent of the global population.
Still, by making advanced market commitments, they collectively store almost five billion doses of vaccines,” point out.
The US has held at least six bilateral transactions, amounted to more than one billion doses – more than enough to examinate the entire American population.
The European Union, England and Canada each signed seven bilateral transactions, with the potential to secure enough doses to cover their population two, four and six times more.
Dr.
Agarwal said that the political compulsion of the election of democratic governments in developed countries can be understood because they need to win their own people’s approval by prioritizing their health for all the others.
However, these countries must attack the fine balance to share supplies of vaccines, releasing patent protection, loosening export control in the materials used for vaccine production, and reducing vaccine costs for poor countries.
Creating a strong case to build a diplomatic-based international political influence, he suggested to adjust the ‘vaccine continuum’ as a must that would reflect global willingness to trust the pandemic and secure the health and welfare of mankind.
“Eradication Covid-19 requires a universal vision and global leadership.
Vaccination benefits must permeate in most parts of the world if the human population must develop a herd of flock and stop the deadly virus game,” the debate is from Agarwal.